Characteristic | 25(OH)D <20 ng/mL (n = 186) | 25(OH) ≥20 ng/mL (n = 114) | P value |
---|---|---|---|
Age (years) | 64 (SD 16) | 69 (SD 15) | < 0.01 |
Sex (%) | Â | Â | 0.67 |
 Female | 41 | 44 |  |
 Male | 59 | 56 |  |
Race (%) | Â | Â | 0.14 |
 Non-white | 12 | 6 |  |
 White | 88 | 94 |  |
BMI (kg/m2) | 29 (SD 8) | 28 (SD 6) | 0.22 |
SES | Â | Â | 0.09 |
 Low | 26 | 25 |  |
 Moderate | 39 | 41 |  |
 High | 36 | 33 |  |
Patient type (%) | Â | Â | 0.21 |
 Emergent | 16 | 10 |  |
 Non-emergent | 84 | 90 |  |
APACHE II | 17 (SD 9) | 15 (SD 7) | 0.03 |
Hospital LOS (days) | 9 (IQR 6–15) | 9 (IQR 6–12) | 0.32 |
Vitamin D supplementation (%) | Â | Â | < 0.01 |
 <1000 IU/day | 88 | 72 |  |
 ≥1000 to <4000 IU/day | 12 | 28 |  |
25OHD (ng/mL) | 14 (SD 4) | 27 (SD 7) | < 0.001 |
In-hospital mortality (%) | Â | Â | 0.03 |
 Alive | 80 | 91 |  |
 Deceased | 20 | 9 |  |
Discharge destination (%) | Â | Â | < 0.01 |
 Non-home | 48 | 29 |  |
 Home | 52 | 71 |  |